Ultrasound Targeted Microbubble Destruction for Novel Dual Targeting of HSP72 and HSC70 in Prostate Cancer |
Wang, Hang-Hui
(Department of Ultrasound, Shanghai First People's Hospital, School of Medicine, Shanghai Jiaotong University)
Song, Yi-Xin (Department of Ultrasound, Shanghai First People's Hospital, School of Medicine, Shanghai Jiaotong University) Bai, Min (Department of Ultrasound, Shanghai First People's Hospital, School of Medicine, Shanghai Jiaotong University) Jin, Li-Fang (Department of Ultrasound, Shanghai First People's Hospital, School of Medicine, Shanghai Jiaotong University) Gu, Ji-Ying (Department of Ultrasound, Shanghai First People's Hospital, School of Medicine, Shanghai Jiaotong University) Su, Yi-Jin (Department of Ultrasound, Shanghai First People's Hospital, School of Medicine, Shanghai Jiaotong University) Liu, Long (Department of Ultrasound, Shanghai First People's Hospital, School of Medicine, Shanghai Jiaotong University) Jia, Chao (Department of Ultrasound, Shanghai First People's Hospital, School of Medicine, Shanghai Jiaotong University) Du, Lian-Fang (Department of Ultrasound, Shanghai First People's Hospital, School of Medicine, Shanghai Jiaotong University) |
1 | Alaiya AA, Oppermann M, Langridge J, et al (2001). Identification of proteins in human prostate tumor material by two-dimensional gel electrophoresis and mass spectrometry. Cell Mol Life Sci, 58, 307-11. DOI |
2 | Balaburski GM, Leu JI, Beeharry N, et al (2013). A modifed HSP70 inhibitor shows broad activity as an anticancer agent. Mol Cancer Res, 11, 219-29. DOI |
3 | Bitting RL, Armstrong AJ (2013). Targeting the PI3K/Akt/mTOR pathway in castration-resistant prostate cancer. Endocr Relat Cancer, 20, R83-99. DOI |
4 | Davenport EL, Zeisig A, Aronson LI, et al (2010). Targeting heat shock protein 72 enhances Hsp90 inhibitor-induced apoptosis in myeloma. Leukemia, 24, 1804-7. DOI |
5 | DeSantis C, Naishadham D, Jemal A (2013). Cancer statistics for African Americans, 2013. CA Cancer J Clin, 63, 151-66. DOI ScienceOn |
6 | Di Lorenzo G, Autorino R, Figg WD, et al (2007). Hormone-refractory prostate cancer: Where are we going? Drugs, 67, 1109-24. DOI ScienceOn |
7 | Evans CG, Chang L, Gestwicki JE (2010). Heat shock protein 70 (hsp70) as an emerging drug target. J Med Chem, 53, 4585-602. DOI ScienceOn |
8 | Garcia JA, Rini BI (2012). Castration-resistant prostate cancer: Many treatments, many options, many challenges ahead. Cancer, 118, 2583-93. DOI |
9 | Goloudina AR, Demidov ON, Garrido C (2012). Inhibition of HSP70: a challenging anti-cancer strategy. Cancer Lett, 325, 117-24. DOI |
10 | Matthias MP (2013). Hsp70 chaperone dynamics and molecular mechanism. Trends Biochemical Sciences, 38, 507-14. DOI |
11 | Lebret T, Watson RW, Fitzpatrick JM (2003). Heat shock proteins: their role in urological tumors. J Urol, 169, 338-46. |
12 | Li HL, Zheng XZ, Wang HP, et al (2009). Ultrasound-targeted microbubble destruction enhances AAV-mediated gene transfection in human RPE cells in vitro and rat retina in vivo. Gene Ther, 16, 1146-53. DOI |
13 | McConnell JR, McAlpine SR (2013). Heat shock proteins 27, 40, and 70 as combinational and dual therapeutic cancer targets. Bioorg Med Chem Lett, 23, 1923-28. DOI |
14 | McNamara JO 2nd, Andrechek ER, Wang Y, et al (2006). Cell type-specific delivery of siRNAs with aptamer-siRNA chimeras. Nat Biotechnol, 24, 1005-15. DOI |
15 | Meng L, Hunt C, Yaglom JA, et al (2011). Heat shock protein Hsp72 plays role in Her2-induced mammary tumorigenesis. Oncogene, 30, 2836-45. DOI |
16 | Pai SI, Lin YY, Macaes B, et al (2006). Prospects of RNA interference therapy for cancer. Gene Ther, 13, 464-77. DOI |
17 | Powers MV, Clarke PA, Workman P (2008). Dual targeting of HSC70 and HSP72 inhibits HSP90 function and induces tumor-specific apoptosis. Cancer Cell, 14, 250-62. DOI ScienceOn |
18 | Zheng X, Du L, Wang H, et al (2012). A novel approach to attenuate proliferative vitreoretinopathy using ultrasoundtargeted microbubble destruction and recombinant adenoassociated virus-mediated RNA interference targeting transforming growth factor- and platelet-derived growth factor-B. J Gene Med, 14, 339-47. DOI ScienceOn |
19 | Zuiderweg ER, Bertelsen EB, Rousaki A, et al (2013). Allostery in the Hsp70 chaperone proteins. Top Curr Chem, 328, 99-153. |
20 | Siegel R, Naishadham D, Jemal A (2013). Cancer statistics, 2013. CA Cancer J Clin, 63, 11-30. DOI ScienceOn |
21 | Stangl S, Gehrmann M, Riegger J, et al (2011). Targeting membrane heat-shock protein 70 (Hsp70) on tumors by cmHsp70.1 antibody. Proc Natl Acad Sci USA, 108, 733-38. DOI ScienceOn |
22 | Powers MV, Jones K, Barillari C, et al (2010). Targeting HSP70: the second potentially druggable heat shock protein and molecular chaperone? Cell Cycle, 9, 1542-50. DOI |
23 | Rerole AL, Gobbo J, De Thonel A, et al (2011). Peptides and aptamers targeting HSP70: a novel approach for anticancer chemotherapy. Cancer Res, 71, 484-95. DOI ScienceOn |
24 | Rerole AL, Jego G, Garrido C (2011). Hsp70: anti-apoptotic and tumorigenic protein. Methods Mol Biol, 787, 205-30. DOI ScienceOn |
25 | Suzuki R, Oda Y, Utoguchi N, et al (2011). Progress in the development of ultrasound-mediated gene delivery systems utilizing nano- and microbubbles. J Control Release, 149, 36-41. DOI ScienceOn |
26 | Tachibana K, Uchida T, Ogawa K, et al (1999). Induction of cell-membrane porosity by ultrasound. Lancet, 353, 1409. |
27 | Whitesell L, Lindquist SL (2005). HSP90 and the chaperoning of cancer. Nat Rev Cancer, 5, 761-72. DOI ScienceOn |
28 | Xie W, Liu S, Su H, et al (2010). Ultrasound microbubbles enhance recombinant adeno-associated virus vector delivery to retinal ganglion cells in vivo. Acad Radiol, 17, 1242-48. DOI ScienceOn |
29 | Yao YD, Sun TM, Huang SY, et al (2012). Targeted delivery of PLK1-siRNA by ScFv suppresses Her2+ breast cancer growth and metastasis. Sci Transl Med, 4, 130ra48. |
30 | Daugaard M, Rohde M, Jaattela M (2007). The heat shock protein 70 family: Highly homologous proteins with overlapping and distinct functions. FEBS Lett, 581, 3702-10. DOI ScienceOn |
31 | Garrido C, Schmitt E, Cande C, et al (2003). HSP27 and HSP70: potentially oncogenic apoptosis inhibitors. Cell Cycle, 2, 579-84. |
32 | Jemal A, Bray F, Center MM, et al (2011). Global cancer statistics. CA Cancer J Clin, 61, 69-90. DOI |